BioCardia, Inc., a clinical-stage regenerative medicine company, develops therapies for cardiovascular disease. The company is headquartered in San Carlos, California. Show more

320 SOQUEL WAY, SUNNYVALE, CA, UNITED STATES, 94085, Sunnyvale, CA, 94085, USA

BIOTECHNOLOGY

HEALTHCARE

Start AI Chat

Market Cap

12.1M

52 Wk Range

$1.00 - $3.20

Previous Close

$1.17

Open

$1.17

Volume

71,266

Day Range

$1.10 - $1.20

Enterprise Value

7.556M

Cash

5.287M

Avg Qtr Burn

-1.672M

Insider Ownership

26.67%

Institutional Own.

5.28%

Qtr Updated

09/30/25

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
CardiAMP cell therapy Details Ischemic heart failure with reduced ejection fraction (HFrEF)	Phase 3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
BCDA-01 CardiAMP cell therapy Details Ischemic stroke, Heart failure	Phase 3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
BCDA-03 CardiALLO cell therapy Details Ischemic stroke, Heart failure	Phase 1/2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.